Dr. Wendy Béguelin is a basic and translational research scientist working in the field of lymphoma epigenetics. She obtained her degree of Biology at the University of Buenos Aires, Argentina, where she received extensive training in the investigation of cell biology and signal transduction with studies on epigenetic gene regulation and transcription factor binding. As a postdoctoral scientist at Weill Cornell Medical College, under the mentorship of Prof. Ari Melnick she has identified novel epigenetic and transcriptional mechanisms that contribute to B-cell differentiation and lymphomagenesis. She has studied the biological and transcriptional mechanisms of action of Polycomb proteins in germinal center B-cells and lymphomas derived from germinal centers. As Assistant Professor at Weill Cornell Medicine, Dr. Béguelin is committed to a career in basic/translational cancer research, bringing new ideas into the field of epigenetic control of lymphomagenesis and making discoveries that can be translated from the diagnostic and therapeutic standpoints.